HansBiomed Corporation (KOSDAQ:A042520) announced a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of its shares pursuant to the contract with Shinhan Investment Corp. The purpose of the program is stabilization of stock prices and enhancement of shareholder value.

The program will expire on December 23, 2022. As of June 22, 2022, the company had 337,105 shares within the available dividend range acquisition and no shares under other acquisitions.